Gene Symbol | Pearson Correlation Coefficient |
---|---|
LHFPL3 | 0.788 |
STK32A | 0.744 |
TMEM255A | 0.713 |
SEMA5A | 0.713 |
STK32B | 0.709 |
LUZP2 | 0.7 |
CCDC50 | 0.679 |
BCHE | 0.671 |
HAS2 | 0.665 |
CCND1 | 0.649 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
HIPK4 | -0.378 |
ADPRHL1 | -0.351 |
KSR2 | -0.338 |
CA7 | -0.335 |
PLXNA2 | -0.332 |
VWA7 | -0.327 |
ABCG8 | -0.324 |
BAAT | -0.324 |
CYP4A22 | -0.321 |
CRHR2 | -0.321 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C029497 | 2,3-bis(3'-hydroxybenzyl)butyrolactone | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BLM mRNA" | 19167446 |
C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased expression of BLM mRNA | 19191707 |
D000082 | Acetaminophen | Acetaminophen results in increased expression of BLM mRNA | 22230336 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of BLM mRNA | 17942131 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of BLM mRNA | 22100608 |
C059765 | amphotericin B, deoxycholate drug combination | "amphotericin B, deoxycholate drug combination results in increased expression of BLM mRNA" | 22863853 |
D001151 | Arsenic | Arsenic results in decreased expression of BLM mRNA | 19945496 |
D001280 | Atrazine | Atrazine results in decreased expression of BLM mRNA | 22378314 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of BLM mRNA | 20064835 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of BLM mRNA | 17942131 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BLM mRNA" | 19150397|2038263 |
D004958 | Estradiol | EGF protein inhibits the reaction [Estradiol results in increased expression of BLM mRNA] | 24758408 |
D004958 | Estradiol | [Estradiol co-treated with Progesterone] results in decreased expression of BLM mRNA | 21453500 |
D004958 | Estradiol | Estradiol results in increased expression of BLM mRNA | 17268063|2475840 |
D004958 | Estradiol | fulvestrant inhibits the reaction [Estradiol results in increased expression of BLM mRNA] | 17268063 |
C006780 | bisphenol A | bisphenol A results in decreased expression of BLM mRNA | 29275510 |
C006780 | bisphenol A | bisphenol A results in increased expression of BLM mRNA | 17268063|2212120 |
C006780 | bisphenol A | fulvestrant inhibits the reaction [bisphenol A results in increased expression of BLM mRNA] | 17268063 |
C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in decreased expression of BLM mRNA | 17942131 |
C584509 | C646 compound | C646 compound results in decreased expression of BLM mRNA | 23698071 |
D000068579 | Celecoxib | Celecoxib results in increased expression of BLM mRNA | 28201806 |
D002922 | Ciguatoxins | Ciguatoxins affects the expression of BLM mRNA | 18353800 |
D003078 | Colchicine | Colchicine results in decreased expression of BLM mRNA | 24211769 |
D003300 | Copper | [NSC 689534 binds to Copper] which results in decreased expression of BLM mRNA | 20971185 |
D019327 | Copper Sulfate | Copper Sulfate results in decreased expression of BLM mRNA | 19549813 |
D003375 | Coumestrol | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BLM mRNA" | 19167446 |
D003375 | Coumestrol | [Coumestrol co-treated with resveratrol] results in increased expression of BLM mRNA | 19167446 |
D003375 | Coumestrol | Coumestrol results in increased expression of BLM mRNA | 19167446 |
C408982 | CPG-oligonucleotide | CPG-oligonucleotide results in decreased expression of BLM mRNA | 21878529 |
D003471 | Cuprizone | Cuprizone results in increased expression of BLM mRNA | 26577399 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of BLM mRNA | 20106945 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of BLM mRNA | 17942131 |
D003703 | Demecolcine | Demecolcine results in decreased expression of BLM mRNA | 23649840 |
D002945 | Cisplatin | Cisplatin results in decreased expression of BLM mRNA | 24211769 |
D002945 | Cisplatin | Cisplatin results in increased expression of BLM mRNA | 27594783 |
D002945 | Cisplatin | Cisplatin results in increased expression of BLM mRNA | 21151649 |
C000944 | dicrotophos | dicrotophos results in decreased expression of BLM mRNA | 28302478 |
D002117 | Calcitriol | Calcitriol results in decreased expression of BLM mRNA | 21592394 |
D002117 | Calcitriol | [Testosterone co-treated with Calcitriol] results in decreased expression of BLM mRNA | 21592394 |
D005020 | Ethyl Methanesulfonate | Ethyl Methanesulfonate results in decreased expression of BLM mRNA | 24211769 |
D005038 | Ethylnitrosourea | Ethylnitrosourea results in increased mutagenesis of BLM exon | 17156454 |
D005047 | Etoposide | Etoposide results in decreased expression of BLM mRNA | 24211769 |
D005472 | Fluorouracil | Fluorouracil results in decreased expression of BLM mRNA | 19272435 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [bisphenol A results in increased expression of BLM mRNA] | 17268063 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [Estradiol results in increased expression of BLM mRNA] | 17268063 |
D005839 | Gentamicins | Gentamicins results in decreased expression of BLM mRNA | 22061828 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of BLM mRNA | 20044591 |
D006918 | Hydroxyurea | Hydroxyurea results in decreased expression of BLM mRNA | 24211769 |
D006918 | Hydroxyurea | Hydroxyurea results in increased expression of BLM mRNA | 18647660 |
D007052 | Ibuprofen | Ibuprofen results in increased expression of BLM mRNA | 28201806 |
C056493 | imiquimod | imiquimod results in decreased expression of BLM mRNA | 21878529 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of BLM mRNA | 25613284 |
C544151 | jinfukang | jinfukang results in increased expression of BLM mRNA | 27392435 |
D007854 | Lead | Lead results in decreased expression of BLM mRNA | 19921347 |
C533894 | LG 100815 | LG 100815 results in decreased expression of BLM mRNA | 16951191 |
D008154 | Lucanthone | Lucanthone results in decreased expression of BLM mRNA | 21148553 |
D058185 | Magnetite Nanoparticles | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BLM mRNA | 21641980 |
D008628 | Mercury | Mercury binds to and results in decreased activity of BLM protein | 21440839 |
D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in decreased expression of BLM mRNA | 26011545 |
D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in decreased expression of BLM mRNA | 24211769 |
D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of BLM mRNA | 23649840 |
D016685 | Mitomycin | Mitomycin results in decreased expression of BLM mRNA | 24211769 |
D009151 | Mustard Gas | Mustard Gas results in decreased expression of BLM mRNA | 25102026 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in increased expression of BLM mRNA" | 25554681 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of BLM mRNA" | 25620056 |
C017096 | n-butoxyethanol | n-butoxyethanol results in increased expression of BLM mRNA | 19812364 |
D009532 | Nickel | Nickel results in increased expression of BLM mRNA | 25583101 |
C558013 | NSC 689534 | [NSC 689534 binds to Copper] which results in decreased expression of BLM mRNA | 20971185 |
C062198 | octa-2,4,6-trienoic acid | "octa-2,4,6-trienoic acid results in decreased expression of BLM mRNA" | 16951191 |
C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in decreased expression of BLM mRNA | 25729387 |
C030110 | oxaliplatin | oxaliplatin results in decreased expression of BLM mRNA | 25729387 |
D010100 | Oxygen | Oxygen deficiency results in decreased expression of BLM mRNA | 26516004 |
D010100 | Oxygen | Oxygen deficiency results in increased expression of BLM mRNA | 26476374 |
D010100 | Oxygen | Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of BLM mRNA] | 26476374 |
D010433 | Pentylenetetrazole | Pentylenetetrazole affects the expression of BLM mRNA | 21503142 |
C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in decreased expression of BLM mRNA | 26678675 |
D010634 | Phenobarbital | Phenobarbital affects the expression of BLM mRNA | 23091169 |
D011374 | Progesterone | [Estradiol co-treated with Progesterone] results in decreased expression of BLM mRNA | 21453500 |
C005556 | propionaldehyde | propionaldehyde results in decreased expression of BLM mRNA | 26079696 |
D011794 | Quercetin | Quercetin results in increased expression of BLM mRNA | 21632981 |
D011794 | Quercetin | Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of BLM mRNA] | 26476374 |
C059514 | resveratrol | [Coumestrol co-treated with resveratrol] results in increased expression of BLM mRNA | 19167446 |
C547185 | riccardin D | riccardin D results in decreased expression of and results in decreased activity of BLM protein | 24069304 |
D004113 | Succimer | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BLM mRNA | 21641980 |
D013739 | Testosterone | [Testosterone co-treated with Calcitriol] results in decreased expression of BLM mRNA | 21592394 |
D013739 | Testosterone | Testosterone results in decreased expression of BLM mRNA | 21592394 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of BLM mRNA | 21570461 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of BLM mRNA | 25613284 |
D019284 | Thapsigargin | Thapsigargin results in increased expression of BLM protein | 24648495 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of BLM mRNA | 27865774 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of BLM mRNA | 27404394 |
D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in decreased expression of BLM mRNA | 25729387 |
D019772 | Topotecan | Topotecan results in decreased expression of BLM mRNA | 25729387 |
C496197 | trans-10,cis-12-conjugated linoleic acid | "trans-10,cis-12-conjugated linoleic acid results in decreased expression of BLM mRNA" | 17951470 |
D014212 | Tretinoin | Tretinoin results in increased expression of BLM mRNA | 20488242 |
C015559 | trimellitic anhydride | trimellitic anhydride results in increased expression of BLM mRNA | 19042947 |
C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BLM mRNA" | 26179874 |
C057693 | troglitazone | troglitazone results in decreased expression of BLM mRNA | 19140230 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of BLM mRNA | 23179753|2718838 |
D014750 | Vincristine | Vincristine results in decreased expression of BLM mRNA | 23649840 |
D000225 | Adenine | Adenine results in decreased expression of BLM mRNA | 24211769 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000400 | four-way junction DNA binding | - | IBA | 21873635 |
GO:0000400 | four-way junction DNA binding | - | IDA | 11735402 20639533 25901030 |
GO:0000403 | Y-form DNA binding | - | IBA | 21873635 |
GO:0000403 | Y-form DNA binding | - | IDA | 11735402 |
GO:0000405 | bubble DNA binding | - | IBA | 21873635 |
GO:0000405 | bubble DNA binding | - | IDA | 11433031 11735402 |
GO:0002039 | p53 binding | - | IBA | 21873635 |
GO:0002039 | p53 binding | - | IPI | 11781842 |
GO:0003677 | DNA binding | - | IBA | 21873635 |
GO:0003677 | DNA binding | - | IDA | 24816114 |
GO:0003678 | DNA helicase activity | - | IDA | 19734539 |
GO:0003697 | single-stranded DNA binding | - | IBA | 21873635 |
GO:0003697 | single-stranded DNA binding | - | IDA | 12818200 20639533 |
GO:0004003 | ATP-dependent DNA helicase activity | - | IDA | 9388193 24816114 25901030 |
GO:0004003 | ATP-dependent DNA helicase activity | - | IMP | 21325134 |
GO:0004386 | helicase activity | - | IDA | 10871376 12181313 17878217 |
GO:0005515 | protein binding | - | IPI | 10728666 10825162 11309417 11919194 12181313 12975363 14688284 15229185 15775963 15965237 16030011 16864798 17961633 20360068 20711169 20826342 21240188 21325134 23509288 23708797 24126761 26496610 |
GO:0005524 | ATP binding | - | IBA | 21873635 |
GO:0005524 | ATP binding | - | IDA | 17878217 24816114 25901030 |
GO:0008026 | ATP-dependent helicase activity | - | IDA | 12818200 |
GO:0008094 | DNA-dependent ATPase activity | - | IDA | 24816114 25901030 |
GO:0008270 | zinc ion binding | - | IBA | 21873635 |
GO:0008270 | zinc ion binding | - | IDA | 24816114 25901030 |
GO:0009378 | four-way junction helicase activity | - | IBA | 21873635 |
GO:0009378 | four-way junction helicase activity | - | IDA | 11433031 11735402 12818200 25901030 |
GO:0016887 | ATPase activity | - | IDA | 17878217 |
GO:0036310 | annealing helicase activity | - | IBA | 21873635 |
GO:0036310 | annealing helicase activity | - | IDA | 17878217 |
GO:0042803 | protein homodimerization activity | - | IBA | 21873635 |
GO:0042803 | protein homodimerization activity | - | IDA | 28228481 |
GO:0043140 | ATP-dependent 3'-5' DNA helicase activity | - | IBA | 21873635 |
GO:0051880 | G-quadruplex DNA binding | - | IDA | 11433031 11735402 |
GO:0061749 | forked DNA-dependent helicase activity | - | IBA | 21873635 |
GO:0061749 | forked DNA-dependent helicase activity | - | IDA | 11735402 25901030 |
GO:0061821 | telomeric D-loop binding | - | IBA | 21873635 |
GO:0061821 | telomeric D-loop binding | - | IDA | 19734539 |
GO:0061849 | telomeric G-quadruplex DNA binding | - | IC | 19734539 |
GO:1905773 | 8-hydroxy-2'-deoxyguanosine DNA binding | - | IBA | 21873635 |
GO:1905773 | 8-hydroxy-2'-deoxyguanosine DNA binding | - | IDA | 19734539 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | - | IBA | 21873635 |
GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | - | IMP | 15604258 |
GO:0000712 | resolution of meiotic recombination intermediates | - | IBA | 21873635 |
GO:0000724 | double-strand break repair via homologous recombination | - | IBA | 21873635 |
GO:0000724 | double-strand break repair via homologous recombination | - | NAS | 11309417 |
GO:0000729 | DNA double-strand break processing | - | IDA | 21325134 |
GO:0000731 | DNA synthesis involved in DNA repair | - | IBA | 21873635 |
GO:0000732 | strand displacement | - | IBA | 21873635 |
GO:0000733 | DNA strand renaturation | - | IEA | - |
GO:0006260 | DNA replication | - | ISS | - |
GO:0006260 | DNA replication | - | TAS | - |
GO:0006281 | DNA repair | - | IBA | 21873635 |
GO:0006281 | DNA repair | - | NAS | 7585968 |
GO:0006303 | double-strand break repair via nonhomologous end joining | - | IBA | 21873635 |
GO:0006310 | DNA recombination | - | IBA | 21873635 |
GO:0006310 | DNA recombination | - | NAS | 7585968 10728666 |
GO:0006974 | cellular response to DNA damage stimulus | - | IDA | 23509288 |
GO:0006974 | cellular response to DNA damage stimulus | - | IMP | 12818200 |
GO:0007095 | mitotic G2 DNA damage checkpoint | - | IBA | 21873635 |
GO:0007095 | mitotic G2 DNA damage checkpoint | - | IDA | 11309417 |
GO:0010165 | response to X-ray | - | IBA | 21873635 |
GO:0010165 | response to X-ray | - | IDA | 11309417 |
GO:0010705 | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination | - | IBA | 21873635 |
GO:0031297 | replication fork processing | - | IBA | 21873635 |
GO:0031297 | replication fork processing | - | IDA | 17115688 |
GO:0032508 | DNA duplex unwinding | - | IBA | 21873635 |
GO:0032508 | DNA duplex unwinding | - | IDA | 11735402 24816114 25901030 |
GO:0043066 | negative regulation of apoptotic process | - | IBA | 21873635 |
GO:0044806 | G-quadruplex DNA unwinding | - | IBA | 21873635 |
GO:0044806 | G-quadruplex DNA unwinding | - | IDA | 11735402 |
GO:0044806 | G-quadruplex DNA unwinding | - | ISS | - |
GO:0045003 | double-strand break repair via synthesis-dependent strand annealing | - | IBA | 21873635 |
GO:0045893 | positive regulation of transcription, DNA-templated | - | IBA | 21873635 |
GO:0045893 | positive regulation of transcription, DNA-templated | - | IDA | 11781842 |
GO:0045910 | negative regulation of DNA recombination | - | IMP | 9671747 |
GO:0045950 | negative regulation of mitotic recombination | - | IBA | 21873635 |
GO:0046632 | alpha-beta T cell differentiation | - | IBA | 21873635 |
GO:0046641 | positive regulation of alpha-beta T cell proliferation | - | IBA | 21873635 |
GO:0048478 | replication fork protection | - | NAS | 10779560 |
GO:0051259 | protein complex oligomerization | - | IDA | 10359700 28228481 |
GO:0051260 | protein homooligomerization | - | IBA | 21873635 |
GO:0051260 | protein homooligomerization | - | IDA | 28228481 |
GO:0051307 | meiotic chromosome separation | - | IBA | 21873635 |
GO:0051782 | negative regulation of cell division | - | IBA | 21873635 |
GO:0051782 | negative regulation of cell division | - | IMP | 11781842 |
GO:0061820 | telomeric D-loop disassembly | - | IBA | 21873635 |
GO:0061820 | telomeric D-loop disassembly | - | IDA | 19734539 |
GO:0070244 | negative regulation of thymocyte apoptotic process | - | IBA | 21873635 |
GO:0071139 | resolution of recombination intermediates | - | IBA | 21873635 |
GO:0071479 | cellular response to ionizing radiation | - | IBA | 21873635 |
GO:0071479 | cellular response to ionizing radiation | - | IDA | 23509288 |
GO:0072711 | cellular response to hydroxyurea | - | IBA | 21873635 |
GO:0072711 | cellular response to hydroxyurea | - | IDA | 23509288 |
GO:0072757 | cellular response to camptothecin | - | IDA | 23509288 |
GO:0090329 | regulation of DNA-dependent DNA replication | - | IBA | 21873635 |
GO:0090329 | regulation of DNA-dependent DNA replication | - | IMP | 25901030 |
GO:0090656 | t-circle formation | - | TAS | 27918544 |
GO:1901291 | negative regulation of double-strand break repair via single-strand annealing | - | IBA | 21873635 |
GO:1905168 | positive regulation of double-strand break repair via homologous recombination | - | IBA | 21873635 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000228 | nuclear chromosome | - | IBA | 21873635 |
GO:0000228 | nuclear chromosome | - | IDA | 23509288 |
GO:0000781 | chromosome, telomeric region | COLOCALIZES_WITH | IBA | 21873635 |
GO:0000781 | chromosome, telomeric region | colocalizes_with | IDA | 10779560 |
GO:0000800 | lateral element | - | IBA | 21873635 |
GO:0000800 | lateral element | - | IDA | 10728666 |
GO:0005634 | nucleus | - | IBA | 21873635 |
GO:0005634 | nucleus | - | IDA | 9388480 11500040 |
GO:0005654 | nucleoplasm | - | TAS | - |
GO:0005657 | replication fork | - | IBA | 21873635 |
GO:0005657 | replication fork | - | ISS | - |
GO:0005694 | chromosome | - | IBA | 21873635 |
GO:0005730 | nucleolus | - | IBA | 21873635 |
GO:0005730 | nucleolus | - | IDA | 10779560 |
GO:0005737 | cytoplasm | - | IBA | 21873635 |
GO:0005829 | cytosol | - | IBA | 21873635 |
GO:0005829 | cytosol | - | IDA | - |
GO:0016363 | nuclear matrix | - | IBA | 21873635 |
GO:0016363 | nuclear matrix | - | IDA | 11309417 |
GO:0016605 | PML body | COLOCALIZES_WITH | IBA | 21873635 |
GO:0016605 | PML body | - | IDA | 10728666 |
GO:0016605 | PML body | colocalizes_with | IDA | 10779560 |
GO:0045120 | pronucleus | - | IBA | 21873635 |
KEGG ID | KEGG Term |
---|---|
hsa03440 | Homologous recombination |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-1474165 | Reproduction | IEA |
R-HSA-1500620 | Meiosis | IEA |
R-HSA-1640170 | Cell Cycle | TAS |
R-HSA-1640170 | Cell Cycle | IEA |
R-HSA-212436 | Generic Transcription Pathway | TAS |
R-HSA-2990846 | SUMOylation | TAS |
R-HSA-3108214 | SUMOylation of DNA damage response and repair proteins | TAS |
R-HSA-3108232 | SUMO E3 ligases SUMOylate target proteins | TAS |
R-HSA-3700989 | Transcriptional Regulation by TP53 | TAS |
R-HSA-392499 | Metabolism of proteins | TAS |
R-HSA-5633007 | Regulation of TP53 Activity | TAS |
R-HSA-5685938 | HDR through Single Strand Annealing (SSA) | TAS |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | TAS |
R-HSA-5693532 | DNA Double-Strand Break Repair | TAS |
R-HSA-5693537 | Resolution of D-Loop Structures | TAS |
R-HSA-5693538 | Homology Directed Repair | TAS |
R-HSA-5693554 | Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | TAS |
R-HSA-5693567 | HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA) | TAS |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | TAS |
R-HSA-5693579 | Homologous DNA Pairing and Strand Exchange | TAS |
R-HSA-5693607 | Processing of DNA double-strand break ends | TAS |
R-HSA-5693616 | Presynaptic phase of homologous DNA pairing and strand exchange | TAS |
R-HSA-597592 | Post-translational protein modification | TAS |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | TAS |
R-HSA-69473 | G2/M DNA damage checkpoint | TAS |
R-HSA-69481 | G2/M Checkpoints | TAS |
R-HSA-69620 | Cell Cycle Checkpoints | TAS |
R-HSA-73857 | RNA Polymerase II Transcription | TAS |
R-HSA-73894 | DNA Repair | TAS |
R-HSA-74160 | Gene expression (Transcription) | TAS |
R-HSA-912446 | Meiotic recombination | IEA |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
21861943 | Folate malabsorption is associated with down-regulation of folate transporter expression and function at colon basolateral membrane in rats. (2012 Mar) | Wani NA | Br J Nutr |
22956120 | Decreased activity of folate transporters in lipid rafts resulted in reduced hepatic folate uptake in chronic alcoholism in rats. (2013 Mar) | Wani NA | Genes Nutr |
18008023 | Decreased expression of transporters reduces folate uptake across renal absorptive surfaces in experimental alcoholism. (2007 Dec) | Hamid A | J Membr Biol |
24924712 | [Study on gene-gene, gene-environmental interactions of DNA repair genes related with age-related cataract]. (2014 Apr 22) | Yang M | Zhonghua Yi Xue Za Zhi |
10826102 | The effect of trifluoperazine on the genotoxicity of bleomycin in cultured human lymphocytes. (2000 May) | Sadiq MF | Drug Chem Toxicol |
17953974 | Inherited susceptibility to bleomycin-induced micronuclei: correlating polymorphisms in GSTT1, GSTM1 and DNA repair genes with mutagen sensitivity. (2008 Feb 1) | Angelini S | Mutat Res |